日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial.

参与 II 期临床试验的神经母细胞瘤患儿的纵向 NK 细胞动力学和细胞毒性

Nguyen Rosa, Sahr Natasha, Sykes April, McCarville Mary Beth, Federico Sara M, Sooter Amanda, Cullins David, Rooney Barbara, Janssen William E, Talleur Aimee C, Triplett Brandon M, Anthony Gwendolyn, Dyer Michael A, Pappo Alberto S, Leung Wing H, Furman Wayne L

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

一项人源化抗GD2单克隆抗体(hu14.18K322A)联合化疗和自然杀伤细胞治疗复发/难治性神经母细胞瘤患儿的试点试验

Federico, Sara M; McCarville, M Beth; Shulkin, Barry L; Sondel, Paul M; Hank, Jacquelyn A; Hutson, Paul; Meagher, Michael; Shafer, Aaron; Ng, Catherine Y; Leung, Wing; Janssen, William E; Wu, Jianrong; Mao, Shenghua; Brennan, Rachel C; Santana, Victor M; Pappo, Alberto S; Furman, Wayne L

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

一项随机II期研究,旨在评估他克莫司联合西罗莫司或甲氨蝶呤在异基因造血干细胞移植后的疗效。

Pidala, Joseph; Kim, Jongphil; Jim, Heather; Kharfan-Dabaja, Mohamed A; Nishihori, Taiga; Fernandez, Hugo F; Tomblyn, Marcie; Perez, Lia; Perkins, Janelle; Xu, Mian; Janssen, William E; Veerapathran, Anandaraman; Betts, Brian C; Locke, Frederick L; Ayala, Ernesto; Field, Teresa; Ochoa, Leonel; Alsina, Melissa; Anasetti, Claudio